Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
16.76
+0.34 (2.07%)
Nov 5, 2024, 4:00 PM EST - Market closed
Tyra Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 99.49 | 58.01 | 251.21 | 302.18 | 15.22 | 0.11 |
Short-Term Investments | 274.31 | 145.46 | - | - | - | - |
Cash & Short-Term Investments | 373.8 | 203.47 | 251.21 | 302.18 | 15.22 | 0.11 |
Cash Growth | 60.83% | -19.01% | -16.87% | 1884.91% | 13996.30% | - |
Other Receivables | 1.9 | 0.7 | - | - | - | - |
Receivables | 1.9 | 0.7 | - | - | - | - |
Prepaid Expenses | 2.88 | 7.5 | 6.08 | 1.88 | 0.06 | 0.02 |
Total Current Assets | 378.57 | 211.67 | 257.29 | 304.06 | 15.28 | 0.13 |
Property, Plant & Equipment | 8.19 | 8.15 | 3.54 | 2.09 | 0.47 | 0.28 |
Long-Term Deferred Charges | - | - | - | - | - | 0.11 |
Other Long-Term Assets | 5.69 | 6.03 | 5.35 | 0.56 | 0.26 | 0.02 |
Total Assets | 392.46 | 225.86 | 266.18 | 306.7 | 16.01 | 0.53 |
Accounts Payable | 1.58 | 4.66 | 1.15 | 0.55 | 0.66 | 0.33 |
Accrued Expenses | 8.42 | 10.39 | 4.42 | 2.86 | 1.05 | 0.36 |
Current Portion of Leases | 0.38 | 0.28 | 0.14 | 0.2 | 0.14 | 0.14 |
Other Current Liabilities | - | - | - | - | - | 4.33 |
Total Current Liabilities | 10.38 | 15.33 | 5.7 | 3.62 | 1.86 | 5.16 |
Long-Term Leases | 6.02 | 6.22 | 2.48 | 0.98 | - | 0.11 |
Other Long-Term Liabilities | 0.02 | 0.05 | 0.17 | 0.37 | 0.14 | - |
Total Liabilities | 16.42 | 21.6 | 8.35 | 4.96 | 2 | 5.27 |
Common Stock | 0.01 | 0 | 0 | 0 | - | - |
Additional Paid-In Capital | 577.95 | 368.71 | 353.52 | 342.1 | 0.44 | - |
Retained Earnings | -201.72 | -164.83 | -95.7 | -40.37 | -14.08 | -4.74 |
Comprehensive Income & Other | -0.18 | 0.38 | - | - | - | - |
Total Common Equity | 376.04 | 204.26 | 257.83 | 301.74 | -13.64 | -4.74 |
Shareholders' Equity | 376.04 | 204.26 | 257.83 | 301.74 | 14.01 | -4.74 |
Total Liabilities & Equity | 392.46 | 225.86 | 266.18 | 306.7 | 16.01 | 0.53 |
Total Debt | 6.4 | 6.5 | 2.62 | 1.18 | 0.14 | 0.25 |
Net Cash (Debt) | 367.4 | 196.97 | 248.59 | 301 | 15.08 | -0.15 |
Net Cash Growth | 62.32% | -20.76% | -17.41% | 1895.75% | - | - |
Net Cash Per Share | 7.47 | 4.61 | 5.94 | 21.84 | 9.78 | -0.05 |
Filing Date Shares Outstanding | 52.74 | 52.52 | 42.43 | 41.11 | 1.83 | 2.65 |
Total Common Shares Outstanding | 52.74 | 43.02 | 42.35 | 40.95 | 1.83 | 2.65 |
Working Capital | 368.19 | 196.34 | 251.59 | 300.44 | 13.42 | -5.03 |
Book Value Per Share | 7.13 | 4.75 | 6.09 | 7.37 | -7.45 | -1.79 |
Tangible Book Value | 376.04 | 204.26 | 257.83 | 301.74 | -13.64 | -4.74 |
Tangible Book Value Per Share | 7.13 | 4.75 | 6.09 | 7.37 | -7.45 | -1.79 |
Machinery | 2.48 | 2.03 | 1.38 | 1.06 | 0.34 | 0.03 |
Leasehold Improvements | 0.47 | 0.4 | 0.16 | 0.14 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.